Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators. Bel EH, et al. Among authors: pavord id. N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199060 Free article. Clinical Trial.
The epithelial era of asthma research: knowledge gaps and future direction for patient care.
Brightling CE, Marone G, Aegerter H, Chanez P, Heffler E, Pavord ID, Rabe KF, Uller L, Dorscheid D; Epithelial Science Expert Group. Brightling CE, et al. Among authors: pavord id. Eur Respir Rev. 2024 Dec 18;33(174):240221. doi: 10.1183/16000617.0221-2024. Print 2024 Oct. Eur Respir Rev. 2024. PMID: 39694589 Free PMC article. Review.
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
Singh D, Brightling CE, Rabe KF, Han MK, Christenson SA, Drummond MB, Papi A, Pavord ID, Molfino NA, Almqvist G, Kotalik A, Hellqvist Å, Gołąbek M, Sindhwani NS, Ponnarambil SS; COURSE study investigators. Singh D, et al. Among authors: pavord id. Lancet Respir Med. 2024 Dec 6:S2213-2600(24)00324-2. doi: 10.1016/S2213-2600(24)00324-2. Online ahead of print. Lancet Respir Med. 2024. PMID: 39653044
Stability of Fractional Exhaled Nitric Oxide and its Relationship with Exacerbation in Patients Aged 6 Years or Older with Uncontrolled, Moderate-to-Severe Asthma.
Busse WW, Pavord ID, Wechsler ME, Davila IJ, Altincatal A, de Prado Gomez L, Soler X, Sacks H, Jacob-Nara JA, Deniz Y, Rowe PJ. Busse WW, et al. Among authors: pavord id. Chest. 2024 Dec 2:S0012-3692(24)05601-0. doi: 10.1016/j.chest.2024.09.048. Online ahead of print. Chest. 2024. PMID: 39631682 Free article. No abstract available.
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.
Ramakrishnan S, Russell REK, Mahmood HR, Krassowska K, Melhorn J, Mwasuku C, Pavord ID, Bermejo-Sanchez L, Howell I, Mahdi M, Peterson S, Bengtsson T, Bafadhel M. Ramakrishnan S, et al. Among authors: pavord id. Lancet Respir Med. 2024 Nov 27:S2213-2600(24)00299-6. doi: 10.1016/S2213-2600(24)00299-6. Online ahead of print. Lancet Respir Med. 2024. PMID: 39615502 Free article.
Dupilumab Induces Long-term On-Treatment Clinical Remission in Patients With Type 2 Asthma.
Pavord ID, Rabe KF, Israel E, Szefler SJ, Brusselle G, Pandit-Abid N, Altincatal A, Chen Z, Amin N, Khan AH, Lederer DJ, Zhang Y, Rowe PJ, Deniz Y, Radwan A, Jacob-Nara JA, Busse WW. Pavord ID, et al. J Allergy Clin Immunol Pract. 2024 Oct 16:S2213-2198(24)01063-8. doi: 10.1016/j.jaip.2024.10.009. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39424189 Free article.
Biologics in Asthma: Role of Biomarkers.
Lavoie G, Pavord ID. Lavoie G, et al. Among authors: pavord id. Immunol Allergy Clin North Am. 2024 Nov;44(4):709-723. doi: 10.1016/j.iac.2024.08.003. Epub 2024 Sep 2. Immunol Allergy Clin North Am. 2024. PMID: 39389719 Review.
Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies.
Wechsler ME, Brusselle G, Virchow JC, Bourdin A, Kostikas K, Llanos JP, Roseti SL, Ambrose CS, Hunter G, Jackson DJ, Castro M, Lugogo N, Pavord ID, Martin N, Brightling CE. Wechsler ME, et al. Among authors: pavord id. Eur Respir J. 2024 Dec 5;64(6):2400316. doi: 10.1183/13993003.00316-2024. Print 2024 Dec. Eur Respir J. 2024. PMID: 39326921 Free PMC article. Clinical Trial.
442 results